79
Views
1
CrossRef citations to date
0
Altmetric
Original Article

The Leukointegrin Alpha d/Beta2 (αd/CD18): Specific Changes in Surface Expression in Patients on Hemodialysis

, , , , &
Pages 13-20 | Received 01 Apr 1997, Accepted 13 Jan 1998, Published online: 11 Jul 2009

References

  • Arnaout M.A., et al. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N. Engl. J. Med. 1985; 312: 457–62
  • Arnaout M.A. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 1990; 75: 1037–50
  • Brady H. Leukocyte adhesion molecules and kidney diseases. Kidney Int. 1994; 45: 1285–1300
  • Chatenoud L. Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity. Proc. Natl. Acad. Sci. USA 1986; 83: 7457–61
  • Craddock P.R., et al. Complement and leucocyte-mediated pulmonary dysfunction in hemodialysis. N. Engl. J. Med. 1977; 296: 769–74
  • Eschbach J.W., et al. 14C cyanate as a tag for red cell survival in normal and uremic man. J. Lab. Clin. Med. 1977; 89: 823
  • Goldblum S.E., Reed W.P. Host defenses and immunologic alterations associated with chronic hemodialysis. Ann. Intern. Med. 1980; 93: 597–613
  • Hakim R.M. Clinical implications of hemodialysis membrane biocompatibility. Kidney Int. 1993; 44: 484–94
  • Hakim R.M., et al. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N. Engl. J. Med. 1994; 331: 1338–42
  • Harlan J.M. Leukocyte adhesion deficiency syndrome: insights into the molecular basis of leukocyte emigration. Clin. Immunol. Immunopath. 1993; 67: 16–24
  • Himmelfarb J., et al. Modulation of granulocyte LAM-1 and MAC-1 during dialysis - a prospective, randomized controlled trial. Kidney Int. 1992; 41: 338–45
  • Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11–25
  • Keane W.F., Raij L. Host defenses and infectious complications in maintenance hernodialysis patients. Replacement of Renal Function by Dialysis, 2nd Ed, W. Drukker, F.M. Parson, J.F. Maher. Martinus Nijhoff, Boston 1983; 646–58
  • Lundahl J., et al. Dialysis granulocytopenia is preceded by an increased surface expression of the adhesion-promoting glycoprotein Mac-1. Nephron 1992; 61: 163–9
  • Mahajan S., et al. Relationship between pulmonary functions and hemodialysis induced leukopenia. Trans. Am. Soc. Artif. Inter. Organs. 1977; 23: 411–5
  • Murota S., et al. Adhesion molecule mediated endothelial cell injury elicited by activated leukocytes. Ann. NY Acad. Sciences 1995; 748: 133–47
  • Nelson C., et al. Genetic cause of leukocyte adhesion molecule deficiency: abnormal splicing and a missense mutation in a conserved region of CD 18 impair cell surface expression of β2 integrins. J. Biol. Chem. 1992; 267: 3351–7
  • Rabb H. Cell adhesion molecules and the kidney. Am. J. Kidney Dis. 1994a; 23: 155–66
  • Rabb H., et al. Activated and regulatory T lymphocyte populations in chronic hemodialysis patients. Am. J. Kid. Dis. 1994b; 24: 43–52
  • Rabb H., et al. Alterations in soluble and leukocyte surface L-selectin (CD62L) in HD patients. J. Am. Soc. Nephrol. 1995; 6: 1445–50
  • Rabb H., et al. Alterations in soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in hemodialysis patients. Am. J. Kid. Dis. 1996a; 27: 239–43
  • Rabb H., et al. CD 18 deficient cows have attenuated leukopenia during hemodialysis. J. Am. Soc. Nephrol. 1996b; 7: 1716
  • Rabb H., et al. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int. 1997; 51: 1463–68
  • Springer T.A. Adhesion receptors of the immune system. Nature 1990; 346: 425–34
  • Stuard S., et al. A major role for CD62P/CD15s interaction in leukocyte margination during HD. Kidney Int. 1995; 48: 93–102
  • U.S. Renal Data System. USRDS, 1994 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 1994
  • Van Der Vieren M., et al. A novel leukointegrin, αdβ2, binds preferentially to ICAM-3. Immunity 1995; 3: 683–90

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.